Table 5. Pathologic and oncologic outcomes.
Variables | Median (interquartile range) or counts (%) | P | |
---|---|---|---|
OPN (N = 64) | RPN (N = 85) | ||
Tumor size (cm) | 3.1 (2.3–4.8) | 4.3 (2.9–5.2) | 0.014 |
Pathological stage | 4 (6.3%) | 1 (1.2%) | 0.165 |
pT1 | 57 (89.1%) | 74 (87.1%) | |
pT2 | 3 (4.7%) | 10 (11.8%) | |
pT3 | 4 (6.3%) | 1 (1.2%) | |
Fuhrmann grade | 0.386 | ||
≤ 2 | 36 (56.3%) | 40 (47.1%) | |
≥ 3 | 28 (43.8%) | 45 (52.9%) | |
Histological subtype | 0.203 | ||
Clear cell | 50 (78.1%) | 65 (76.5%) | |
Papillary | 3 (4.7%) | 1 (1.2%) | |
Chromophobe | 3 (4.7%) | 10 (11.8%) | |
Collecting duct | 0 (0%) | 0 (0%) | |
Unclassified | 0 (0%) | 2 (2.4%) | |
Benign | 8 (12.5%) | 7 (8.2%) | |
Positive surgical margin | 1 (1.6%) | 0 (0%) | 0.432 |
Recurrence | 2 (3.1%) | 4 (4.7%) | 0.306 |
Overall mortality | 3 (4.7%) | 0 (0%) | 0.077 |
Follow-up duration, months | 53.0 (33.3–81.0) | 15.0 (5.5–33.0) | <0.001 |
OPN, open partial nephrectomy; RPN, robotic partial nephrectomy